Vital Signs

Showing 31-40 of 307

This issue of Vital Signs, released on December 11, 2006, provides a strategic overview of the impact of reimbursement reductions by CMS on power mobility devices. Additionally, an emerging company profile is provided for Invacare Corporation, a leader in the development of home and long-term medical care products for the acute and non-acute care m...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on December 18, 2006, provides a strategic overview of the rise in use of point-of-care testing (POCT) and physician office laboratories. Additionally, an emerging company profile is provided for Abaxis Inc., a leader in the development of POCT blood analyzers for the medical and veterinary markets. Reimbursement...

USD 1,500.00

USD 1,125.00 save 25 %

This research service provides an exhaustive overview of vital signs monitoring and the current trends in vital sign monitoring technologies . It discusses the latest technologies that have revolutionized the vital signs monitoring industry as of today, and offers strategic recommendations on expanding the scope and use of vital sign monitors.

USD 4,950.00

USD 3,712.50 save 25 %

This issue of Vital Signs, released on January 15, 2007, provides a strategic overview of the use of computer aided detection and diagnosis in medical imaging. Additionally, an emerging company profile is provided for Medipattern Corp., a leader in the development of CAD imaging software solutions for the medical imaging industry. Reimbursement and...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on January 22, 2007, provides a strategic overview of the impact of government regulation rules on the adoption of electronic medical records. Additionally, an emerging company profile is provided for StatCom, a leader in the providing of patient flow logistics and tracking software solutions. Reimbursement and r...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on January 29, 2007, provides a strategic overview of the importance of ROI considerations in the remote patient monitoring market. Additionally, an emerging company profile is provided for Honeywell HomMed, a leader in the home telehealth system industry. Reimbursement and regulatory news from the FDA and CMS is...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on February 5, 2007, provides a strategic overview of how health technology assessments (HTA) are changing competition dynamics in the healthcare industry, and how companies can use HTAs to their advantage. Additionally, an emerging company profile is provided for Atritech Inc., a company focused on developing in...

USD 1,500.00

USD 1,125.00 save 25 %

12 Feb 2007  |  North America

Vital Signs - In Acquisitions We Trust

 

This issue of Vital Signs, released on February 12, 2007, provides a strategic overview of important acquisition criteria for M&A activities in the pharmaceutical industry. Additionally, an emerging company profile is provided for AmpliMed Corporation, a clinical stage pharmaceutical company specializing in small molecule oncology drugs. Reimbursem...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on February 19, 2007, provides a strategic overview of the importance of healthcare industry collaboration for biomarker identification and clinical use. Additionally, an emerging company profile is provided for BioMarker Pharmaceuticals, a company focused on exploiting genetic differences to combat aging and obe...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on February 26, 2007, provides a strategic overview of the potential impact of changes to the warfarin drug label on pharmacogenetic testing. Additionally, an emerging company profile is provided for Tm Bioscience Corporation, a clinical diagnostics company involved in manufacturing and marketing genetic tests. R...

USD 1,500.00

USD 1,125.00 save 25 %

Showing 31-40 of 307